Joy Liu - 17 May 2021 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
SVP, General Counsel
Signature
/s/ Sabrina Yohai, Attorney-in-Fact
Issuer symbol
VRTX
Transactions as of
17 May 2021
Net transactions value
-$24,230
Form type
4
Filing time
19 May 2021, 16:06:13 UTC
Next filing
03 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Sale $14,037 -65 -0.78% $215.95 8,300 17 May 2021 Direct F1, F2, F3
transaction VRTX Common Stock Sale $10,193 -47 -0.57% $216.88 8,253 17 May 2021 Direct F1, F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1.
F2 Open market sales reported on this line occurred at a weighted average price of $215.95 (range $215.42 to $216.34).
F3 Ms. Liu undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
F4 Open market sales reported on this line occurred at a weighted average price of $216.88 (range $216.43 to $217.21).